Key responsibilities:

• Lead the global integrated product access strategy across the full product lifecycle, ensuring clear differentiation and strong value proposition for payers, patients, and healthcare stakeholders
• Drive the global reimbursement process for OAV101, including leading advocacy efforts to secure public reimbursement
• Develop and execute market access strategies in partnership with Medical, Commercial, HEOR, and Public Affairs teams
• Support country teams in payer negotiations and ensure timely delivery of high-quality access materials
• Ensure access perspectives are embedded in TPPs, clinical development programs, BD&L assessments, and lifecycle planning
• Identify and drive evidence generation (beyond registration trials) to meet payer, HTA, and stakeholder requirements in key geographies
• Collaborate closely with HEOR and PCO teams to integrate robust economic and outcomes evidence into cross-franchise strategies
• Lead and develop a team (3 direct reports: 2 leads, 1 manager across Toronto and Montreal) while managing budgets and access community initiatives
• Ensure compliance with pharmacovigilance requirements, including reporting adverse events within 24 hours

Essential Requirements:

• Minimum 5+ years of experience in Market Access, Pricing, or HEOR roles within the pharmaceutical industry
• Experience in early drug development and/or product launch strategy execution
• Proven ability to lead cross-functional initiatives in a matrix environment and influence senior stakeholders
• Strong experience driving commercial strategies through access, pricing, or HEOR insights
• Demonstrated strategic thinking and data-driven decision-making capabilities
• Excellent communication and stakeholder engagement skills
• Ability to lead complex global projects and advocacy efforts

Desirable Requirements:

• 7+ years of experience in Market Access
• Experience in Neuroscience, Gene Therapy, or other relevant therapeutic areas

At Novartis Canada, we are determined to be a valued partner and advocate, with a deep understanding of patient needs along the entire care journey – from drug development, to diagnosis, to access and beyond. Part of the way we are doing this is by leveraging data, technology, and partnerships.

Research & Development: we focus on four core therapeutic areas: Cardiovascular, Renal & Metabolic, Immunology, Neuroscience and Oncology. We also develop and deliver treatments through other promoted and established brands, which today are helping millions of patients. Over the last three years, our average annual research and development investment in Canada was over $30 million, and we conduct clinical trial research in every region throughout Canada.

Commitment to Diversity and Inclusion: Novartis is committed to building outstanding, inclusive work environment and diverse team’s representatives of the patients and communities we serve.